Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacists on Plan B

This article was originally published in The Tan Sheet

Executive Summary

A recent survey of 859 U.S. pharmacists reveals that 69% believe they should "have the authority to refuse filling prescriptions for emergency contraception" such as Barr Labs' Plan B. However, 37% of pharmacists feel they should also be required to refer patients to a pharmacist willing to fill the prescription. The poll, conducted Dec. 3-4 by HCD Research, was prompted by the suspension of four Walgreens pharmacists in Illinois who refused to comply with a state law mandating that pharmacists fill EC prescriptions. The retailer placed the employees on unpaid leave but offered to transfer them to Missouri where no such law exists. One pharmacist has returned after agreeing to acknowledge state law...

You may also be interested in...



US High Court Punts On ‘Objective Falsity’ FCA Standard

Can a false-claims suit be filed if doctors have different opinions about whether a treatment was necessary? The Supreme Court won’t say.

AstraZeneca Cashes In Moderna Chips

The firms' messenger RNA alliance inked back on 2013 is still very much ongoing but AstraZeneca decided to sell its considerable stake in the high-profile biotech to help finance its own pipeline.

White House To Deliver 25 Million Face Masks To Low-Income Americans

The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.

Topics

UsernamePublicRestriction

Register

ID1135947

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel